NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies

Susan Dent, Karen A. Gelmon, K. N., Derek J. Jonker, Nancy Wainman, C. A. Capier, Eric X. Chen, John F. Lyons, Lesley Seymour

Investigational New Drugs · 2013 · 23 citations · 22 references

Concepts

References

22